Live feed
Filing
SC 13G/A
SC 13G/A0000929638-17-000873·ABRAMS CAPITAL, LLC
Schedule 13G ownership disclosure
KERYX BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 492515101
Event date: 2017-11-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-17-000873
- Form type
- SC 13G/A
- Filer
- ABRAMS CAPITAL, LLC
- CIK
- CIK 1112443
- Filed
- Nov 20, 2017
- Reporting period
- Nov 10, 2017
- Description
- Schedule 13G beneficial ownership